Hypothesis / aims of study
Stress urinary incontinence (SUI) is a common problem, especially among women of reproductive and postmenopausal age. The pathology significantly reduces the quality of life of female patients, causing psychological discomfort and limitations in social activity. Modern non-invasive treatment methods, such as extracorporeal electromagnetic stimulation (ES), are becoming an important direction in the therapy of SUI.
To evaluate the efficacy of extracorporeal electromagnetic stimulation in women with SUI type 1-2 using ultrasound monitoring of the pelvic floor muscles before and after treatment.
Study design, materials and methods
The study included 20 women aged 35 to 45 years with diagnosed SUI type 1-2.
All participants underwent an initial examination including history, urinary diaries, pelvic floor ultrasound (PFU) and completion of the ICIQ-UI SF questionnaire.
Patients received ES treatment at a frequency of 2 sessions per week, 10 sessions total. The duration of one session was 20 min.
The procedure was performed on the Salus Talent Pro device, power 3 Tesla.
The stimulation mode was multimodal with a combination of frequencies from 2-3 Hz to 35 Hz. This frequency spectrum corresponds to the modes of operation of the nervous system in the alpha and betta rhythm, has a stimulating effect on the nervous system, and as a consequence, the inclusion of muscle-tone effect.
Ultrasound control of the pelvic floor muscles was carried out before and after the course of treatment.
Clinical dynamics was assessed according to the ICIQ-UI SF scale and subjective feelings of the patients.
Interpretation of results
Compared to other non-surgical interventions for SUI, such as pelvic floor muscle training (PFMT) or intravaginal electrical stimulation, ES appears to offer comparable or superior outcomes with less dependence on patient compliance. PFMT, although effective, often requires months of consistent practice to achieve results, and adherence rates can be low. In contrast, ES provides passive stimulation without requiring active participation from the patient, making it a more convenient option for individuals with busy lifestyles or limited access to supervised therapy.
Moreover, the safety profile of ES is favorable, with no adverse events reported during the study period. This contrasts with invasive treatments like midurethral sling surgery, which, while highly effective, carry risks of complications such as infection, erosion, or voiding dysfunction. For women seeking a minimally invasive yet efficacious solution, ES represents a promising alternative.